Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
Condition(s):TuberculosisLast Updated:March 18, 2020Completed
Hide Studies Not Open or Pending
Condition(s):TuberculosisLast Updated:March 18, 2020Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:September 29, 2021Not yet recruiting
Condition(s):TuberculosisLast Updated:August 22, 2018Completed
Condition(s):Tuberculosis; Drug-resistant TuberculosisLast Updated:November 1, 2019Unknown status
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:March 31, 2022Recruiting
Condition(s):TuberculosisLast Updated:March 22, 2017Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:November 1, 2021Completed
Condition(s):TuberculosisLast Updated:November 11, 2021Terminated
Condition(s):HIV/AIDS; TB – Tuberculosis; Antiretroviral Therapy, Highly ActiveLast Updated:April 5, 2022Completed
Condition(s):Tuberculosis, Pulmonary; Tuberculosis, Multidrug Resistant; Extensively Drug-Resistant TuberculosisLast Updated:December 1, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.